[go: up one dir, main page]

NO951350D0 - Pharmaceutical preparations containing 3-substituted 2-oxindole-1-carboxamides - Google Patents

Pharmaceutical preparations containing 3-substituted 2-oxindole-1-carboxamides

Info

Publication number
NO951350D0
NO951350D0 NO951350A NO951350A NO951350D0 NO 951350 D0 NO951350 D0 NO 951350D0 NO 951350 A NO951350 A NO 951350A NO 951350 A NO951350 A NO 951350A NO 951350 D0 NO951350 D0 NO 951350D0
Authority
NO
Norway
Prior art keywords
oxindole
carboxamides
substituted
pharmaceutical preparations
preparations containing
Prior art date
Application number
NO951350A
Other languages
Norwegian (no)
Other versions
NO951350L (en
Inventor
Imran Ahmed
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO951350D0 publication Critical patent/NO951350D0/en
Publication of NO951350L publication Critical patent/NO951350L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO951350A 1992-10-07 1995-04-06 Pharmaceutical preparations containing 3-substituted 2-oxindole-1-carboxamides NO951350L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95793092A 1992-10-07 1992-10-07
PCT/US1993/008063 WO1994007488A1 (en) 1992-10-07 1993-09-02 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Publications (2)

Publication Number Publication Date
NO951350D0 true NO951350D0 (en) 1995-04-06
NO951350L NO951350L (en) 1995-06-06

Family

ID=25500362

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951350A NO951350L (en) 1992-10-07 1995-04-06 Pharmaceutical preparations containing 3-substituted 2-oxindole-1-carboxamides

Country Status (21)

Country Link
EP (1) EP0662831A1 (en)
JP (1) JP2721042B2 (en)
KR (1) KR950703338A (en)
CN (1) CN1089138A (en)
AU (1) AU676200B2 (en)
BR (1) BR9307182A (en)
CA (1) CA2146448A1 (en)
CZ (1) CZ282702B6 (en)
EG (1) EG20289A (en)
FI (1) FI934387L (en)
HU (1) HUT68533A (en)
IL (1) IL107122A (en)
MX (1) MX9306222A (en)
MY (1) MY109680A (en)
NO (1) NO951350L (en)
NZ (1) NZ256164A (en)
PL (1) PL174170B1 (en)
RU (1) RU2119353C1 (en)
TW (1) TW438798B (en)
WO (1) WO1994007488A1 (en)
ZA (1) ZA937405B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2076106B1 (en) * 1993-08-26 1996-06-16 Pfizer PHARMACEUTICAL COMPOSITIONS BASED ON 2-OXINDOL-1-CARBOXAMIDES 3-SUBSTITUTED
AU2517095A (en) * 1994-05-19 1995-12-18 R.P. Scherer International Corporation Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
SK51296A3 (en) * 1995-04-24 1997-04-09 Pfizer Inhibiting photodecomposition of 3-substituted-2-oxindol-1- -carboxamides, a tablet and a capsule
WO1998029136A1 (en) * 1996-12-27 1998-07-09 Takeda Chemical Industries, Ltd. Stabilized tricyclic compound
JP5869764B2 (en) * 2011-01-07 2016-02-24 中日本カプセル 株式会社 Capsule filling composition
JP2022553635A (en) * 2019-10-25 2022-12-26 カーディオル セラピューティクス インコーポレイテッド Cannabidiol composition for use in treating cardiac conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US5036099A (en) * 1987-02-02 1991-07-30 Pfizer Inc. Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
AU634358B2 (en) * 1990-03-02 1993-02-18 Shiseido Company Ltd. Oil-in-water emulsion composition containing nonsteroidal antiphlogistic analgesic
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
EP0620728B1 (en) * 1992-01-13 1997-01-08 Pfizer Inc. Preparation of tablets of increased strength

Also Published As

Publication number Publication date
HUT68533A (en) 1995-04-27
HU9302821D0 (en) 1993-12-28
MY109680A (en) 1997-04-30
ZA937405B (en) 1995-04-06
TW438798B (en) 2001-06-07
IL107122A (en) 1998-08-16
IL107122A0 (en) 1993-12-28
BR9307182A (en) 1999-03-30
EP0662831A1 (en) 1995-07-19
CZ282702B6 (en) 1997-09-17
KR950703338A (en) 1995-09-20
MX9306222A (en) 1994-04-29
NO951350L (en) 1995-06-06
PL308307A1 (en) 1995-07-24
CN1089138A (en) 1994-07-13
AU676200B2 (en) 1997-03-06
CZ87895A3 (en) 1995-10-18
PL174170B1 (en) 1998-06-30
JPH07507809A (en) 1995-08-31
NZ256164A (en) 1997-03-24
EG20289A (en) 1998-07-30
FI934387A0 (en) 1993-10-06
CA2146448A1 (en) 1994-04-14
JP2721042B2 (en) 1998-03-04
RU2119353C1 (en) 1998-09-27
WO1994007488A1 (en) 1994-04-14
FI934387A7 (en) 1994-04-08
AU4839293A (en) 1994-04-26
FI934387L (en) 1994-04-08

Similar Documents

Publication Publication Date Title
FI924340L (en) PHARMACEUTICAL PREPARATIONS
NO942923L (en) drugs
DK0589843T3 (en) Cyclosporin-containing pharmaceutical preparations
NO954146D0 (en) Coated pharmaceutical preparations
FI930882A0 (en) PHARMACEUTICAL FORM
NO922506L (en) PHARMACEUTICAL PREPARATIONS
NO922005D0 (en) PHARMACEUTICAL PREPARATIONS
FI932445L (en) PHARMACEUTICAL ASSOCIATIONS
NO931831D0 (en) PHARMACEUTICAL MIXTURES
FI913100A7 (en) Pharmaceutical preparations
NO934145D0 (en) Pharmaceutical compounds
FI931251A0 (en) PHARMACEUTICAL FORM
DK0925273T3 (en) Pharmaceutical preparations containing 4-oxo-butanoic acids
FI930719A7 (en) PHARMACEUTICAL ASSOCIATIONS
EE9800275A (en) Prolonged-release pharmaceutical preparations containing misolastin
NO951350D0 (en) Pharmaceutical preparations containing 3-substituted 2-oxindole-1-carboxamides
FI923869L (en) PHARMACEUTICAL SUBSTANCE
ZA924111B (en) Pharmaceutical preparations
NO179907C (en) Benzoquinoxalines and pharmaceutical preparations containing the same
NO920039D0 (en) PHARMACEUTICAL PREPARATIONS
NO920564L (en) PHARMACEUTICAL ADENOS-CONTAINING PREPARATIONS
DK75791D0 (en) NOVEL PHARMACEUTICAL PREPARATIONS
ITMI922580A1 (en) PHARMACEUTICAL COMPOSITION
ITMI922581A1 (en) PHARMACEUTICAL COMPOSITION
SE9202820D0 (en) PHARMACEUTICAL COMPOSITION